Results
|
|
81.
|
[Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey]. [electronic resource] by
- Guo, R
- Xiu, B Q
- Su, Y H
- Wang, J
- Zhang, Q
- Chi, W R
- Li, L
- Yang, B L
- Zhang, Y Y
- Cao, A Y
- Shao, Z M
- Wu, J
Producer: 20190927
In:
Zhonghua wai ke za zhi [Chinese journal of surgery] vol. 57
Availability: No items available.
|
|
|
82.
|
[Current trends of breast reconstruction after mastectomy in China: a cross-sectional study]. [electronic resource] by
- Xiu, B Q
- Guo, R
- Yang, B L
- Zhang, Q
- Wang, J
- Su, Y H
- Li, L
- Ji, W R
- Zhang, Y Y
- Cao, A Y
- Shao, Z M
- Wu, J
Producer: 20191007
In:
Zhonghua zhong liu za zhi [Chinese journal of oncology] vol. 41
Availability: No items available.
|
|
|
83.
|
[Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai]. [electronic resource] by
- Wu, F
- Mo, M
- Qin, X X
- Fang, H
- Zhao, G M
- Liu, G Y
- Chen, Y Y
- Cao, Z G
- Yan, Y J
- Lyu, L L
- Xu, W H
- Shao, Z M
Producer: 20180315
In:
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi vol. 38
Availability: No items available.
|
|
|
84.
|
PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy. [electronic resource] by
- Chen, Y Z
- Xue, J Y
- Chen, C M
- Yang, B L
- Xu, Q H
- Wu, F
- Liu, F
- Ye, X
- Meng, X
- Liu, G Y
- Shen, Z Z
- Shao, Z M
- Wu, J
Producer: 20130110
In:
Cancer chemotherapy and pharmacology vol. 70
Availability: No items available.
|
|
|
85.
|
Delineation of the cardiac substructures based on PET-CT and contrast-enhanced CT in patients with left breast cancer treated with postoperative radiotherapy. [electronic resource] by
- Yu, X-L
- Zhang, Q
- Chen, J-Y
- Zhang, Z
- Wang, J-Z
- Hu, W-G
- Pan, Z-Q
- Hu, S-L
- Zhang, Y-J
- Feng, Y
- Shao, Z-M
- Orecchia, R
- Guo, X-M
Producer: 20130715
In:
Technology in cancer research & treatment vol. 12
Availability: No items available.
|
|
|
86.
|
Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer. [electronic resource] by
- Zhang, J
- Lin, Y
- Sun, X J
- Wang, B Y
- Wang, Z H
- Luo, J F
- Wang, L P
- Zhang, S
- Cao, J
- Tao, Z H
- Wu, J
- Shao, Z M
- Yang, W T
- Hu, X C
Producer: 20191223
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|